Essays on the Drug Discovery Innovation System
Date
2017
Authors
Sarkissian, Alfred
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Despite the increase in scientific, monetary, and human resources devoted to drug discovery R&D, the annual number of FDA-approved drugs has been almost unchanged for decades. This study seeks clues to the R&D productivity paradox by exploring the drivers and barriers to innovation in the pharmaceutical industry. The main focus is on the contribution of science and knowledge form external sources to innovation.
Description
Keywords
Public policy, Breakthrough Innovations, Drug Discovery Innovation, Eroom’s Law, Innovation System, Orange Book, Patent Analysis